Enveric Biosciences's total assets for Q3 2024 were $4.79M, a decrease of -20.84% from the previous quarter. ENVB total liabilities were $839.17K for the fiscal quarter, a 30.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.